Dinesh V Ph D Patel, President and CEO at Protagonist Therapeutics, sold PTGX on Sep 10, 2026
Data as of Oct 16
▼ SELL$1M7,278 shares at $144.10Dinesh V Ph D Patel President and CEOPTGX Protagonist Therapeutics, Inc
- Traded
- Sep 10, 2026
- Disclosed
- Sep 10, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PTGX since disclosure
−11.3%
after the sale
Similar stocks (XLV) since disclosure
+6.7%
XLV — its sector index fund
Change in closing price from Sep 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLDinesh V Ph D Patel President and CEOPTGX Protagonist Therapeutics, Inc$9.3Mdisclosed Sep 10 · filed 1 day after the trade
- ▼ SELLDinesh V Ph D Patel President and CEOPTGX Protagonist Therapeutics, Inc$7.9Mdisclosed Sep 10 · filed 2 days after the trade